DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 205 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,621,146 | +8.5% | 583,693 | -5.1% | 0.02% | +13.6% |
| Q2 2023 | $7,946,317 | +16.7% | 615,040 | -11.4% | 0.02% | 0.0% |
| Q1 2023 | $6,809,543 | +112696.8% | 694,143 | +22.1% | 0.02% | -12.0% |
| Q4 2022 | $6,037 | -99.9% | 568,290 | +6.9% | 0.02% | +8.7% |
| Q3 2022 | $5,555,000 | -53.9% | 531,744 | -42.9% | 0.02% | +9.5% |
| Q2 2022 | $12,060,000 | +84.4% | 931,500 | +60.1% | 0.02% | +5.0% |
| Q1 2022 | $6,541,000 | -4.0% | 581,961 | +20.2% | 0.02% | +17.6% |
| Q4 2021 | $6,817,000 | +12.9% | 484,113 | +35.8% | 0.02% | +13.3% |
| Q3 2021 | $6,036,000 | +4.3% | 356,449 | -39.4% | 0.02% | 0.0% |
| Q2 2021 | $5,789,000 | +2519.5% | 588,166 | +6498.2% | 0.02% | +1400.0% |
| Q3 2015 | $221,000 | – | 8,914 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |